SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-013290
Filing Date
2016-05-13
Accepted
2016-05-13 16:31:20
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0316_dandritbiotech.htm 10-Q 407628
2 CERTIFICATION f10q0316ex31i_dandrit.htm EX-31.1 8752
3 CERTIFICATION f10q0316ex32i_dandrit.htm EX-32.1 5036
  Complete submission text file 0001213900-16-013290.txt   2658998

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ddrt-20160331.xml EX-101.INS 405229
5 XBRL SCHEMA FILE ddrt-20160331.xsd EX-101.SCH 33346
6 XBRL CALCULATION FILE ddrt-20160331_cal.xml EX-101.CAL 46893
7 XBRL DEFINITION FILE ddrt-20160331_def.xml EX-101.DEF 72655
8 XBRL LABEL FILE ddrt-20160331_lab.xml EX-101.LAB 306448
9 XBRL PRESENTATION FILE ddrt-20160331_pre.xml EX-101.PRE 188986
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54478 | Film No.: 161648829
SIC: 2834 Pharmaceutical Preparations